Gastrointestinal submucosal extracellular matrix glycoproteins

Gastrointestinal submucosal extracellular matrix glycoproteins represent a diverse group of structural and adhesive molecules, including fibronectin, laminin, and various collagens, located beneath the gastrointestinal epithelium (Source: PubMed, PMID: 11552018). Under normal physiological conditions, these glycoproteins are sequestered from the luminal environment; however, they become exposed when the mucosal barrier is breached, such as in peptic ulcer disease or severe gastritis (Source: StatPearls). These exposed molecules serve as the pharmacological target for mucosal protectant drugs, most notably sucralfate and bismuth-containing compounds (Source: DrugBank). In the acidic environment of the stomach, sucralfate undergoes polymerization to form a negatively charged, sticky paste that selectively binds to the positively charged proteins and glycoproteins within the ulcerated submucosa (Source: Goodman & Gilman's). This interaction creates a physical shield that protects the underlying tissue from the corrosive effects of gastric acid, pepsin, and bile salts, thereby promoting mucosal healing and preventing further injury (Source: PubChem).

Other names

Exposed ulcer proteinsSubmucosal ECM glycoproteinsUlcer base proteinsExposed submucosal proteins

Mucosal protectant drugs bind to these exposed glycoproteins to form a physical barrier that shields the ulcerated tissue from gastric acid and digestive enzymes.